Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mudcat who wrote (29394)	11/15/1999 8:34:00 PM
From: RXGOLF	Read Replies (2) \| Respond to of 32384

<<Overall not a great report in my opinion, maybe you can tell me why the stock is up a half in after hour trading?>> Because I sold some today at $10!! After reading the report I was glad I sold a bit. After someone saying it was 10.75 after hours, I wasn't so pleased with my logical trade<g>. Maybe we aren't seeing what other are looking at?????????

To: Mudcat who wrote (29394)	11/15/1999 8:41:00 PM
From: Gregory Rasp	Respond to of 32384

I think ONTAK and Panretin gels are not much to hang your hat on. These are loser drugs in my opinion. The pipeline is the reason for considering ownership of this stock. You see CTCL is one of the rarest of all cancers. While there is no cure, there are a large number of treatments available. When a patient gets to the stage that chemo is useable they usually die quickly or are too sick for chemo. KS is also rare except in AIDS and those patients are often uninsured and are spending too much on antivirals to waste money treating the KS. GR